日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Bispecific antibodies and CAR T cells targeting a TP53 mutation-associated neoantigen show discordant affinity requirements.

针对TP53突变相关新抗原的双特异性抗体和CAR T细胞表现出不一致的亲和力要求。

DiNapoli Sarah R, Wright Katharine M, Mog Brian J, Pearlman Alexander H, Nichakawade Tushar D, Marcou Nikita, Hsiue Emily Han-Chung, Hwang Michael S, Douglass Jacqueline, Liu Qiang, Watson Evangeline, Dal Molin Marco, Cohen Joshua D, Popoli Maria, Paul Suman, Konig Maximilian F, Wyhs Nicolas, Azurmendi P Aitana, Glavaris Stephanie, Ge Jiaxin, Awosika Tolulope O, Liu Jin, Gabrielson Kathleen L, Gabelli Sandra B, Pardoll Drew M, Bettegowda Chetan, Papadopoulos Nickolas, Kinzler Kenneth W, Zhou Shibin, Vogelstein Bert

Biodegradable targeted polymeric mRNA nanoparticles enable in vivo CD19 CAR T cell generation and lead to B cell depletion.

可生物降解的靶向聚合物 mRNA 纳米颗粒能够实现体内 CD19 CAR T 细胞的生成,并导致 B 细胞耗竭。

Jain Manav, Est-Witte Savannah E, Shannon Sydney R, Neshat Sarah Y, Yu Xinjie, Dunham Sydney, Tian Tina, Cheng Leonardo, Harris Jawaun, Konig Maximilian F, Tzeng Stephany Y, Schneck Jonathan P, Green Jordan J

Detection of Human Brain Cancers using Genomic and Immune Cell Characterization of Cerebrospinal Fluid through CSF-BAM

利用脑脊液基因组和免疫细胞特征分析技术,通过CSF-BAM检测人类脑癌

Pearlman, Alexander H; Wang, Yuxuan; Kalluri, Anita; Parker, Megan; Cohen, Joshua D; Dudley, Jonathan; Rincon-Torroella, Jordina; Xia, Yuanxuan; Gensler, Ryan; Alfonzo Horowitz, Melanie; Theodore, John N; Dobbyn, Lisa; Popoli, Maria; Ptak, Janine; Silliman, Natalie; Judge, Kathy; Calabresi, Peter A; Groves, Mari; Jackson, Christopher M; Jackson, Eric M; Jallo, George I; Lim, Michael; Luciano, Mark; Mukherjee, Debraj; Naidoo, Jarushka; Rozati, Sima; Sterling, Cole H; Weingart, Jon; Koschmann, Carl; Mansouri, Alireza; Glantz, Michael; Kamson, David; Schreck, Karisa C; Pardo, Carlos A; Holdhoff, Matthias; Konig, Maximilian F; Paul, Suman; Kinzler, Kenneth W; Papadopoulos, Nickolas; Vogelstein, Bert; Douville, Christopher; Bettegowda, Chetan

TRBC2-targeting antibody-drug conjugates for the treatment of T cell cancers.

靶向 TRBC2 的抗体药物偶联物用于治疗 T 细胞癌。

Ge Jiaxin, Urban Joshua, DiNapoli Sarah R, Lee Bum Seok, Ahmedna Taha, Nichakawade Tushar D, Mog Brian J, Lu Steve, Li Xuyang, Marcou Nikita, Glavaris Stephanie, Douglass Jacqueline, Liu Jin, Konig Maximilian F, Watson Evangeline, Popoli Maria, Peske J David, Rozati Sima, Sterling Cole H, Wagner-Johnston Nina, Ambinder Richard F, Gabrielson Kathy, Mullighan Charles G, Papadopoulos Nickolas, Bettegowda Chetan, Pardoll Drew M, Zhou Shibin, Sur Surojit, Kinzler Kenneth W, Vogelstein Bert, Paul Suman

Immune-related events in individuals with solid tumors on immunotherapy associate with Th17 and Th2 signatures

接受免疫治疗的实体瘤患者的免疫相关事件与 Th17 和 Th2 特征相关。

Kao, Chester J; Charmsaz, Soren; Alden, Stephanie L; Brancati, Madelena; Li, Howard L; Balaji, Aanika; Munjal, Kabeer; Howe, Kathryn; Mitchell, Sarah; Leatherman, James; Griffin, Ervin; Nakazawa, Mari; Tsai, Hua-Ling; Danilova, Ludmila; Thoburn, Chris; Gizzi, Jennifer; Gross, Nicole E; Hernandez, Alexei; Coyne, Erin M; Shin, Sarah M; Suresh Babu, Jayalaxmi; Apostol, George W; Durham, Jennifer; Christmas, Brian J; Konig, Maximilian F; Lipson, Evan J; Naidoo, Jarushka; Cappelli, Laura C; Pabani, Aliyah; Ged, Yasser; Baretti, Marina; Brahmer, Julie; Hoffman-Censits, Jean; Seiwert, Tanguy Y; Garonce-Hediger, Rachel; Guha, Aditi; Bansal, Sanjay; Tang, Laura; Jaffee, Elizabeth M; Chandler, G Scott; Mohindra, Rajat; Ho, Won Jin; Yarchoan, Mark

Precision targeting of autoreactive B cells in systemic lupus erythematosus using anti-9G4 idiotope synthetic immune receptor T cells.

利用抗9G4特异性合成免疫受体T细胞精确靶向系统性红斑狼疮中的自身反应性B细胞。

Liu Jin, Xia Yuanxuan, Mog Brian J, Gliech Colin, Shaw Elana, Ferris Dylan, Moritz Brock, Awosika Tolulope O, DiNapoli Sarah R, Glavaris Stephanie, Kaeo Kyle J, Li Xuyang, Marcou Nikita, Pearlman Alexander H, Ahmedna Taha S, Bugrovsky Regina, Sanz Iñaki, Bettegowda Chetan, Paul Suman, Alvarado Victoria Duarte, Wirtz Denis, Goldman Daniel, Petri Michelle, Kinzler Kenneth W, Zhou Shibin, Andrade Felipe, Vogelstein Bert, Konig Maximilian F

Preclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densities.

临床前研究表明,Co-STARs 结合了嵌合抗原和 T 细胞受体的优势,可用于治疗抗原密度低的肿瘤

Mog Brian J, Marcou Nikita, DiNapoli Sarah R, Pearlman Alexander H, Nichakawade Tushar D, Hwang Michael S, Douglass Jacqueline, Hsiue Emily Han-Chung, Glavaris Stephanie, Wright Katharine M, Konig Maximilian F, Paul Suman, Wyhs Nicolas, Ge Jiaxin, Miller Michelle S, Azurmendi P, Watson Evangeline, Pardoll Drew M, Gabelli Sandra B, Bettegowda Chetan, Papadopoulos Nickolas, Kinzler Kenneth W, Vogelstein Bert, Zhou Shibin

Autoreactive Plasmablasts After B Cell Depletion With Rituximab and Relapses in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

利妥昔单抗治疗B细胞耗竭后自身反应性浆母细胞的出现及抗中性粒细胞胞浆抗体相关性血管炎的复发

Berti, Alvise; Hillion, Sophie; Konig, Maximilian F; Moura, Marta Casal; Hummel, Amber M; Carmona, Eva; Peikert, Tobias; Fervenza, Fernando C; Kallenberg, Cees G M; Langford, Carol A; Merkel, Peter A; Monach, Paul A; Seo, Philip; Spiera, Robert F; Brunetta, Paul; St Clair, E William; Harris, Kristina M; Stone, John H; Grandi, Guido; Pers, Jacques-Olivier; Specks, Ulrich; Cornec, Divi

Response to: 'Hydroxychloroquine ineffective for COVID-19 prophylaxis in lupus and rheumatoid arthritis' by Singer et al

对 Singer 等人发表的题为“羟氯喹对狼疮和类风湿性关节炎患者的 COVID-19 预防无效”的文章的回应

Ugarte-Gil, Manuel Francisco; Konig, Maximilian F; Korsten, Peter; Berenbaum, Francis; Kim, Alfred Hyoungju; Sparks, Jeffrey A

Response to: 'Correspondence on 'Festina lente: hydroxychloroquine, COVID-19and the role of the rheumatologist' by Graef et al' by Lo et al

Lo 等人对 Graef 等人发表的题为“关于‘Festina lente: hydroxychloroquine, COVID-19 and the role of the rheumatologist’的通信”一文的回应

Duarte-García, Ali; Graef, Elizabeth R; Liew, Jean W; Konig, Maximilian F; Kim, Alfred Hyoungju; Sparks, Jeffrey A